Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Chu Shu, Ji"'
Autor:
Yi-Fu He, Juan Jin, Wei Wei, Yan Chang, Bing Hu, Chu-Shu Ji, Wei-Dong Jia, Xiao-Qiu Wang, Ke Chen, Jian Chen
Publikováno v:
Canadian Journal of Gastroenterology, Vol 24, Iss 7, Pp 435-440 (2010)
BACKGROUND: Many previous studies have evaluated the histopathological features of tumours as risk factors for postoperative recurrence in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). However, there have been few large studies i
Externí odkaz:
https://doaj.org/article/91187b9a6374446ebf702147e96966df
Publikováno v:
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research
BACKGROUND Recently, targeted therapy for malignant tumors has developed rapidly, but there is still no effective targeted therapy for advanced esophageal squamous cell carcinoma (ESCC). Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) is a key enz
Publikováno v:
Oncology Letters. 14:376-382
The present study aimed to investigate the association between periostin (POSTN), epithelial cadherin (E-cad) and vimentin (Vim) expression levels in esophageal squamous cell carcinoma (ESCC) tissues, and its clinicopathological significance. A total
Antitumor and antimetastatic effects of pemetrexed-loaded targeted nanoparticles in B16 bearing mice
Autor:
Pin Wang, Bing Hu, Xiaoling Xu, Baorui Liu, Rutian Li, Nannan Lu, Qin Liu, Chu-Shu Ji, Xing-Hua Han
Publikováno v:
Drug Delivery. 23:2566-2574
Using nanoparticle delivery for anticancer therapy is a potential new drug modality. We developed a novel gelatinase-stimuli nanoparticle. In this study, we studied the antitumor and antimetastasis effect of pemetrexed-loaded targeted nanoparticles a
Autor:
Jian Chen, Jia‑Yu Niu, Wei Wang, Hui‑Qin Luo, Bing Hu, Li‑Hong Ke, Ying Yan, Yi‑Fu He, Jie He, Shu‑Sheng Wu, Shan‑Bao Cai, Xiao‑Xiu Hu, Chu‑Shu Ji, Yi‑Wei Yao, Hui‑Min Li
Publikováno v:
Oncology Letters. 9:2706-2712
The present study aimed to analyze the clinical characteristics and prognosis-related factors of non-small cell lung cancer (NSCLC) patients with bone metastases at the time of diagnosis. A total of 46 NSCLC patients with skeletal metastases at the t
Publikováno v:
Medical Science Monitor; 2/23/2020, Vol. 26, p1-10, 10p
Publikováno v:
OncoTargets and therapy
Wei Jia,1 Wei Wang,1 Chu-shu Ji,1 Jun-yang Niu,2 Ya-jing Lv,1 Hang-cheng Zhou,2 Bing Hu1 1Department of Medical Oncology, 2Department of Pathology, Anhui Provincial Hospital, Anhui Medical University, Hefei, People’s Republic ofChina Background: Bo
Publikováno v:
American journal of cancer research. 6(8)
Drug resistance is one of the main hurdles for the successful treatment of hepatic carcinoma. However, the detailed mechanisms underlying resistance remain largely unknown and therapeutic approaches are limited. In the present study, we show that miR
Autor:
Wei-Dong Jia, Yan Chang, Juan Jin, Xiaoqiu Wang, Bing Hu, Chu-Shu Ji, Wei Wei, Jian Chen, Ke Chen, Yi-Fu He
Publikováno v:
Canadian Journal of Gastroenterology, Vol 24, Iss 7, Pp 435-440 (2010)
BACKGROUND: Many previous studies have evaluated the histopathological features of tumours as risk factors for postoperative recurrence in hepatitis B virus (HBV)-associated hepatocellular carcinoma (HCC). However, there have been few large studies i
Publikováno v:
Medical Oncology. 32
Angiogenic factor with G-patch and FHA domains 1 (AGGF1) is a factor implicating in vascular differentiation and angiogenesis. Several lines of evidence indicate that aberrant expression of AGGF1 is associated with tumor initiation and progression. T